What is Wegovy (semaglutide)?
Wegovy (semaglutide) is a GLP 1 receptor agonist, injected once a week. Wegovy is a higher-dose – 2.4 mg – version of the diabetes drug Ozempic (semaglutide).
Essentially, Wegovy is a weight loss drug which comes in the form of an injection. The active ingredient is a peptide gut hormone that affects the parts of the brain which control appetite and hunger.
How does Wegovy work?
Wegovy slows the emptying of the stomach and promotes a feeling of fullness by acting on the brain.
During clinical trials to evaluate the safety of Wegovy when used for treating obesity, participants without diabetes who were prescribed Wegovy lost on average, 12.4% of their initial body weight when compared to a placebo.
Another clinical trial conducted using participants with type 2 diabetes, found those who took Wegovy lost 6.2 percent of their body weight compared to those who received a placebo.
Reduces food intake by decreasing your appetite.
Slow food digestion in your stomach.
Decreases body fat percentage.
Lowers HA1C levels.
Reduces cardiovascular events in those with Type II DM or cardiovascular disease.
Call today for a consultation and see if Semaglutide is right for you!